Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Unable to match target stats. Using MCMLE estimation.
Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.30684991431181.
The log-likelihood improved by 3.385.
Iteration 2 of at most 500:
Optimizing with step length 0.629996220224275.
The log-likelihood improved by 2.854.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.5744.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.2726.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       21     1113     1020      795      351      387      365 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     326      251      169       91       61       24       17        4 
degree16 degree17 
       2        1 
1 
disease_progression 
H-positive risk:  890 856 116 895 464 127 844 451 117 55 123 62 
H-negative risk:  856 890 844 895 451 464 127 116 123 117 62 55 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
61 new agents 
2 
disease_progression 
H-positive risk:  888 860 117 891 461 128 848 451 117 54 125 60 
H-negative risk:  860 888 848 891 451 461 128 117 125 117 60 54 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
68 new agents 
3 
disease_progression 
H-positive risk:  892 875 117 892 455 129 844 447 115 53 121 60 
H-negative risk:  875 892 844 892 447 455 129 117 121 115 60 53 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
71 new agents 
4 
disease_progression 
H-positive risk:  904 878 118 886 451 131 845 438 115 53 122 59 
H-negative risk:  878 904 845 886 438 451 131 118 122 115 59 53 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 6 3 

clinical_engagement 
diagnosis 
demography 
76 new agents 
5 
disease_progression 
H-positive risk:  906 883 119 883 451 131 850 433 114 51 121 58 
H-negative risk:  883 906 850 883 433 451 131 119 121 114 58 51 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 9 3 

clinical_engagement 
diagnosis 
demography 
52 new agents 
6 
disease_progression 
H-positive risk:  915 887 119 880 448 129 845 434 112 52 120 59 
H-negative risk:  887 915 845 880 434 448 129 119 120 112 59 52 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 9 3 

clinical_engagement 
diagnosis 
demography 
65 new agents 
7 
disease_progression 
H-positive risk:  919 890 122 884 440 129 849 425 114 52 116 60 
H-negative risk:  890 919 849 884 425 440 129 122 116 114 60 52 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 11 3 

clinical_engagement 
diagnosis 
demography 
63 new agents 
8 
disease_progression 
H-positive risk:  921 900 120 882 440 129 851 421 113 51 113 59 
H-negative risk:  900 921 851 882 421 440 129 120 113 113 59 51 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 12 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
9 
disease_progression 
H-positive risk:  922 909 122 875 437 129 853 417 113 51 113 59 
H-negative risk:  909 922 853 875 417 437 129 122 113 113 59 51 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 12 5 

clinical_engagement 
diagnosis 
demography 
68 new agents 
10 
disease_progression 
H-positive risk:  935 911 125 870 434 130 849 415 111 50 112 58 
H-negative risk:  911 935 849 870 415 434 130 125 112 111 58 50 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 13 7 

clinical_engagement 
diagnosis 
demography 
52 new agents 
11 
disease_progression 
H-positive risk:  940 912 123 867 434 129 848 414 112 50 113 58 
H-negative risk:  912 940 848 867 414 434 129 123 113 112 58 50 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 13 7 

clinical_engagement 
diagnosis 
demography 
57 new agents 
12 
disease_progression 
H-positive risk:  942 918 122 871 430 131 839 413 113 49 114 58 
H-negative risk:  918 942 839 871 413 430 131 122 114 113 58 49 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 15 7 

clinical_engagement 
diagnosis 
demography 
63 new agents 
13 
disease_progression 
H-positive risk:  864 843 113 955 421 126 919 408 118 53 121 59 
H-negative risk:  843 864 919 955 408 421 126 113 121 118 59 53 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 17 7 

clinical_engagement 
diagnosis 
demography 
215 new agents 
14 
disease_progression 
H-positive risk:  897 874 115 901 437 137 875 422 110 59 114 59 
H-negative risk:  874 897 875 901 422 437 137 115 114 110 59 59 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 17 7 

clinical_engagement 
diagnosis 
demography 
72 new agents 
15 
disease_progression 
H-positive risk:  897 879 113 904 426 140 880 418 113 55 116 59 
H-negative risk:  879 897 880 904 418 426 140 113 116 113 59 55 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 18 9 

clinical_engagement 
diagnosis 
demography 
57 new agents 
16 
disease_progression 
H-positive risk:  896 887 113 910 425 141 875 413 113 56 112 59 
H-negative risk:  887 896 875 910 413 425 141 113 112 113 59 56 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 18 9 

clinical_engagement 
diagnosis 
demography 
64 new agents 
17 
disease_progression 
H-positive risk:  907 891 115 908 418 143 870 402 115 55 115 61 
H-negative risk:  891 907 870 908 402 418 143 115 115 115 61 55 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 21 10 

clinical_engagement 
diagnosis 
demography 
46 new agents 
18 
disease_progression 
H-positive risk:  911 894 116 907 415 145 868 402 115 53 114 60 
H-negative risk:  894 911 868 907 402 415 145 116 114 115 60 53 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 22 10 

clinical_engagement 
diagnosis 
demography 
66 new agents 
19 
disease_progression 
H-positive risk:  917 893 116 914 415 147 857 399 113 54 114 61 
H-negative risk:  893 917 857 914 399 415 147 116 114 113 61 54 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 24 11 

clinical_engagement 
diagnosis 
demography 
50 new agents 
20 
disease_progression 
H-positive risk:  924 888 117 912 409 150 856 403 112 53 114 62 
H-negative risk:  888 924 856 912 403 409 150 117 114 112 62 53 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 25 10 

clinical_engagement 
diagnosis 
demography 
55 new agents 
21 
disease_progression 
H-positive risk:  933 890 119 909 403 149 862 395 111 52 116 61 
H-negative risk:  890 933 862 909 395 403 149 119 116 111 61 52 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 26 10 

clinical_engagement 
diagnosis 
demography 
68 new agents 
22 
disease_progression 
H-positive risk:  942 893 120 907 396 146 864 388 113 54 116 61 
H-negative risk:  893 942 864 907 388 396 146 120 116 113 61 54 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 28 10 

clinical_engagement 
diagnosis 
demography 
54 new agents 
23 
disease_progression 
H-positive risk:  949 898 122 905 396 146 864 383 109 55 114 59 
H-negative risk:  898 949 864 905 383 396 146 122 114 109 59 55 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 31 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
24 
disease_progression 
H-positive risk:  949 911 123 903 391 148 868 374 109 54 113 57 
H-negative risk:  911 949 868 903 374 391 148 123 113 109 57 54 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 35 13 

clinical_engagement 
diagnosis 
demography 
58 new agents 
25 
disease_progression 
H-positive risk:  887 844 112 976 389 135 935 368 117 54 126 57 
H-negative risk:  844 887 935 976 368 389 135 112 126 117 57 54 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 35 13 

clinical_engagement 
diagnosis 
demography 
162 new agents 
26 
disease_progression 
H-positive risk:  902 872 115 922 412 138 897 395 108 58 127 54 
H-negative risk:  872 902 897 922 395 412 138 115 127 108 54 58 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
57 new agents 
27 
disease_progression 
H-positive risk:  900 879 115 925 410 137 890 401 106 58 126 53 
H-negative risk:  879 900 890 925 401 410 137 115 126 106 53 58 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 37 15 

clinical_engagement 
diagnosis 
demography 
60 new agents 
28 
disease_progression 
H-positive risk:  897 890 117 923 414 137 882 398 103 56 127 56 
H-negative risk:  890 897 882 923 398 414 137 117 127 103 56 56 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 39 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
29 
disease_progression 
H-positive risk:  903 889 117 924 419 137 879 389 104 56 127 56 
H-negative risk:  889 903 879 924 389 419 137 117 127 104 56 56 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 38 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
30 
disease_progression 
H-positive risk:  903 897 119 924 416 137 885 377 105 57 126 54 
H-negative risk:  897 903 885 924 377 416 137 119 126 105 54 57 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 38 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
31 
disease_progression 
H-positive risk:  897 905 120 920 414 137 889 378 106 56 125 53 
H-negative risk:  905 897 889 920 378 414 137 120 125 106 53 56 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 38 14 

clinical_engagement 
diagnosis 
demography 
50 new agents 
32 
disease_progression 
H-positive risk:  908 905 120 908 415 135 885 377 109 55 127 56 
H-negative risk:  905 908 885 908 377 415 135 120 127 109 56 55 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 38 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
33 
disease_progression 
H-positive risk:  906 903 121 909 416 137 890 371 111 55 126 55 
H-negative risk:  903 906 890 909 371 416 137 121 126 111 55 55 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 39 16 

clinical_engagement 
diagnosis 
demography 
48 new agents 
34 
disease_progression 
H-positive risk:  896 907 120 909 413 138 893 373 109 58 130 54 
H-negative risk:  907 896 893 909 373 413 138 120 130 109 54 58 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 40 16 

clinical_engagement 
diagnosis 
demography 
55 new agents 
35 
disease_progression 
H-positive risk:  904 912 121 902 413 138 897 366 106 58 129 54 
H-negative risk:  912 904 897 902 366 413 138 121 129 106 54 58 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 41 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
36 
disease_progression 
H-positive risk:  905 909 124 908 409 140 903 356 107 60 128 51 
H-negative risk:  909 905 903 908 356 409 140 124 128 107 51 60 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 41 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
37 
disease_progression 
H-positive risk:  845 831 115 983 408 131 971 352 119 61 134 50 
H-negative risk:  831 845 971 983 352 408 131 115 134 119 50 61 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 44 18 

clinical_engagement 
diagnosis 
demography 
182 new agents 
38 
disease_progression 
H-positive risk:  863 857 119 951 409 133 935 367 120 65 127 54 
H-negative risk:  857 863 935 951 367 409 133 119 127 120 54 65 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 49 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
39 
disease_progression 
H-positive risk:  861 857 119 956 404 131 937 373 120 64 123 55 
H-negative risk:  857 861 937 956 373 404 131 119 123 120 55 64 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 49 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
40 
disease_progression 
H-positive risk:  867 858 119 965 399 128 934 369 121 64 123 53 
H-negative risk:  858 867 934 965 369 399 128 119 123 121 53 64 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 49 19 

clinical_engagement 
diagnosis 
demography 
53 new agents 
41 
disease_progression 
H-positive risk:  871 861 119 958 397 129 938 369 122 63 120 53 
H-negative risk:  861 871 938 958 369 397 129 119 120 122 53 63 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 49 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
42 
disease_progression 
H-positive risk:  877 865 118 958 396 128 939 365 124 57 119 54 
H-negative risk:  865 877 939 958 365 396 128 118 119 124 54 57 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 49 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
43 
disease_progression 
H-positive risk:  880 864 119 966 387 127 933 366 126 58 121 53 
H-negative risk:  864 880 933 966 366 387 127 119 121 126 53 58 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 51 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
44 
disease_progression 
H-positive risk:  881 860 120 970 385 127 943 356 128 55 123 52 
H-negative risk:  860 881 943 970 356 385 127 120 123 128 52 55 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 50 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
45 
disease_progression 
H-positive risk:  890 866 121 975 376 126 946 352 124 54 117 53 
H-negative risk:  866 890 946 975 352 376 126 121 117 124 53 54 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 50 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
46 
disease_progression 
H-positive risk:  892 860 123 974 378 127 956 343 124 55 116 52 
H-negative risk:  860 892 956 974 343 378 127 123 116 124 52 55 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 50 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
47 
disease_progression 
H-positive risk:  900 863 121 984 371 125 955 337 126 54 114 50 
H-negative risk:  863 900 955 984 337 371 125 121 114 126 50 54 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 51 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
48 
disease_progression 
H-positive risk:  899 866 124 983 369 125 960 333 126 52 114 49 
H-negative risk:  866 899 960 983 333 369 125 124 114 126 49 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 53 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
49 
disease_progression 
H-positive risk:  828 823 119 1028 367 116 1032 327 134 52 123 51 
H-negative risk:  823 828 1032 1028 327 367 116 119 123 134 51 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 53 19 

clinical_engagement 
diagnosis 
demography 
131 new agents 
50 
disease_progression 
H-positive risk:  841 828 120 1012 376 115 1018 336 128 55 118 53 
H-negative risk:  828 841 1018 1012 336 376 115 120 118 128 53 55 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
51 
disease_progression 
H-positive risk:  848 825 119 1006 386 118 1020 328 127 53 116 54 
H-negative risk:  825 848 1020 1006 328 386 118 119 116 127 54 53 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 54 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  851 819 120 1002 387 117 1030 325 125 54 115 55 
H-negative risk:  819 851 1030 1002 325 387 117 120 115 125 55 54 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 53 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
53 
disease_progression 
H-positive risk:  849 823 123 1006 382 117 1034 325 122 52 114 53 
H-negative risk:  823 849 1034 1006 325 382 117 123 114 122 53 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
53 new agents 
54 
disease_progression 
H-positive risk:  856 819 122 1005 382 114 1028 330 121 53 116 54 
H-negative risk:  819 856 1028 1005 330 382 114 122 116 121 54 53 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 52 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
55 
disease_progression 
H-positive risk:  860 814 122 1011 382 112 1023 333 122 55 114 52 
H-negative risk:  814 860 1023 1011 333 382 112 122 114 122 52 55 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 54 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
56 
disease_progression 
H-positive risk:  847 823 125 1004 384 114 1027 332 121 58 114 51 
H-negative risk:  823 847 1027 1004 332 384 114 125 114 121 51 58 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
57 
disease_progression 
H-positive risk:  846 827 127 1004 382 115 1027 327 120 59 116 50 
H-negative risk:  827 846 1027 1004 327 382 115 127 116 120 50 59 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 52 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
58 
disease_progression 
H-positive risk:  848 829 130 1007 379 113 1024 329 119 58 114 50 
H-negative risk:  829 848 1024 1007 329 379 113 130 114 119 50 58 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 53 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
59 
disease_progression 
H-positive risk:  849 833 129 1009 387 113 1019 327 118 55 113 48 
H-negative risk:  833 849 1019 1009 327 387 113 129 113 118 48 55 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
60 
disease_progression 
H-positive risk:  849 842 129 1011 387 113 1012 325 118 52 115 47 
H-negative risk:  842 849 1012 1011 325 387 113 129 115 118 47 52 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 52 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
61 
disease_progression 
H-positive risk:  803 786 124 1074 382 103 1061 323 122 50 125 47 
H-negative risk:  786 803 1061 1074 323 382 103 124 125 122 47 50 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 53 22 

clinical_engagement 
diagnosis 
demography 
127 new agents 
62 
disease_progression 
H-positive risk:  817 794 121 1056 400 101 1027 346 122 50 122 44 
H-negative risk:  794 817 1027 1056 346 400 101 121 122 122 44 50 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
63 
disease_progression 
H-positive risk:  811 800 120 1055 402 99 1026 342 124 50 126 45 
H-negative risk:  800 811 1026 1055 342 402 99 120 126 124 45 50 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 56 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
64 
disease_progression 
H-positive risk:  808 807 120 1057 401 96 1024 339 127 47 126 48 
H-negative risk:  807 808 1024 1057 339 401 96 120 126 127 48 47 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 53 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
65 
disease_progression 
H-positive risk:  811 796 120 1067 398 97 1026 332 128 46 131 48 
H-negative risk:  796 811 1026 1067 332 398 97 120 131 128 48 46 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 57 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
66 
disease_progression 
H-positive risk:  816 794 123 1059 396 96 1021 334 131 47 136 47 
H-negative risk:  794 816 1021 1059 334 396 96 123 136 131 47 47 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 58 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
67 
disease_progression 
H-positive risk:  818 800 122 1065 388 98 1008 335 133 48 138 47 
H-negative risk:  800 818 1008 1065 335 388 98 122 138 133 47 48 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 60 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
68 
disease_progression 
H-positive risk:  821 800 123 1069 390 98 997 334 135 50 135 48 
H-negative risk:  800 821 997 1069 334 390 98 123 135 135 48 50 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 61 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
69 
disease_progression 
H-positive risk:  826 797 124 1068 397 97 989 330 133 52 138 49 
H-negative risk:  797 826 989 1068 330 397 97 124 138 133 49 52 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 62 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
70 
disease_progression 
H-positive risk:  828 803 124 1055 396 97 990 337 129 52 139 50 
H-negative risk:  803 828 990 1055 337 396 97 124 139 129 50 52 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 62 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
71 
disease_progression 
H-positive risk:  831 810 126 1044 396 97 996 331 130 53 137 49 
H-negative risk:  810 831 996 1044 331 396 97 126 137 130 49 53 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 63 23 

clinical_engagement 
diagnosis 
demography 
57 new agents 
72 
disease_progression 
H-positive risk:  827 806 127 1049 394 100 994 329 129 55 140 50 
H-negative risk:  806 827 994 1049 329 394 100 127 140 129 50 55 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
73 
disease_progression 
H-positive risk:  787 768 119 1089 387 98 1040 331 129 56 147 49 
H-negative risk:  768 787 1040 1089 331 387 98 119 147 129 49 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
107 new agents 
74 
disease_progression 
H-positive risk:  780 773 120 1065 410 96 1033 336 127 59 146 55 
H-negative risk:  773 780 1033 1065 336 410 96 120 146 127 55 59 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
104 new agents 
75 
disease_progression 
H-positive risk:  796 777 120 1065 398 96 1033 328 128 60 143 56 
H-negative risk:  777 796 1033 1065 328 398 96 120 143 128 56 60 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
76 
disease_progression 
H-positive risk:  802 780 122 1062 394 96 1032 331 124 60 143 54 
H-negative risk:  780 802 1032 1062 331 394 96 122 143 124 54 60 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
77 
disease_progression 
H-positive risk:  797 782 122 1061 397 94 1037 328 125 61 143 53 
H-negative risk:  782 797 1037 1061 328 397 94 122 143 125 53 61 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
78 
disease_progression 
H-positive risk:  794 785 123 1060 393 94 1035 333 125 61 142 55 
H-negative risk:  785 794 1035 1060 333 393 94 123 142 125 55 61 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 66 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
79 
disease_progression 
H-positive risk:  791 788 124 1059 388 95 1035 334 124 63 144 55 
H-negative risk:  788 791 1035 1059 334 388 95 124 144 124 55 63 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
80 
disease_progression 
H-positive risk:  798 793 123 1050 389 97 1032 335 121 63 145 54 
H-negative risk:  793 798 1032 1050 335 389 97 123 145 121 54 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
81 
disease_progression 
H-positive risk:  796 791 120 1052 391 97 1027 337 119 66 148 56 
H-negative risk:  791 796 1027 1052 337 391 97 120 148 119 56 66 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
82 
disease_progression 
H-positive risk:  792 795 120 1054 389 101 1030 334 119 63 146 57 
H-negative risk:  795 792 1030 1054 334 389 101 120 146 119 57 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
83 
disease_progression 
H-positive risk:  789 793 119 1054 382 105 1038 332 122 62 148 56 
H-negative risk:  793 789 1038 1054 332 382 105 119 148 122 56 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
84 
disease_progression 
H-positive risk:  791 784 118 1064 380 105 1029 340 119 61 153 56 
H-negative risk:  784 791 1029 1064 340 380 105 118 153 119 56 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
85 
disease_progression 
H-positive risk:  729 745 105 1103 384 98 1084 342 128 58 169 55 
H-negative risk:  745 729 1084 1103 342 384 98 105 169 128 55 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
119 new agents 
86 
disease_progression 
H-positive risk:  734 747 103 1096 385 100 1067 350 131 60 172 55 
H-negative risk:  747 734 1067 1096 350 385 100 103 172 131 55 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
87 
disease_progression 
H-positive risk:  730 744 102 1097 381 104 1070 358 130 58 169 57 
H-negative risk:  744 730 1070 1097 358 381 104 102 169 130 57 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
88 
disease_progression 
H-positive risk:  725 740 102 1100 382 104 1067 361 135 56 169 59 
H-negative risk:  740 725 1067 1100 361 382 104 102 169 135 59 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
89 
disease_progression 
H-positive risk:  724 741 100 1096 384 105 1069 360 134 57 168 62 
H-negative risk:  741 724 1069 1096 360 384 105 100 168 134 62 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
90 
disease_progression 
H-positive risk:  733 745 103 1104 378 106 1064 356 132 52 165 62 
H-negative risk:  745 733 1064 1104 356 378 106 103 165 132 62 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
91 
disease_progression 
H-positive risk:  740 746 104 1096 380 106 1059 356 131 52 165 65 
H-negative risk:  746 740 1059 1096 356 380 106 104 165 131 65 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
92 
disease_progression 
H-positive risk:  738 751 103 1103 380 102 1049 360 130 54 163 67 
H-negative risk:  751 738 1049 1103 360 380 102 103 163 130 67 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
93 
disease_progression 
H-positive risk:  738 753 101 1096 382 104 1047 362 128 55 164 70 
H-negative risk:  753 738 1047 1096 362 382 104 101 164 128 70 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
94 
disease_progression 
H-positive risk:  741 748 99 1093 385 108 1045 367 125 54 164 71 
H-negative risk:  748 741 1045 1093 367 385 108 99 164 125 71 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
95 
disease_progression 
H-positive risk:  743 747 101 1091 377 107 1052 367 123 55 165 72 
H-negative risk:  747 743 1052 1091 367 377 107 101 165 123 72 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
96 
disease_progression 
H-positive risk:  739 751 99 1093 374 105 1061 364 121 56 167 70 
H-negative risk:  751 739 1061 1093 364 374 105 99 167 121 70 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
97 
disease_progression 
H-positive risk:  700 704 93 1144 377 102 1103 354 124 56 171 72 
H-negative risk:  704 700 1103 1144 354 377 102 93 171 124 72 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
93 new agents 
98 
disease_progression 
H-positive risk:  696 703 92 1141 391 101 1103 358 126 52 165 72 
H-negative risk:  703 696 1103 1141 358 391 101 92 165 126 72 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
99 
disease_progression 
H-positive risk:  698 702 91 1144 388 102 1097 361 133 50 164 70 
H-negative risk:  702 698 1097 1144 361 388 102 91 164 133 70 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
100 
disease_progression 
H-positive risk:  706 704 91 1142 385 102 1088 365 132 51 163 71 
H-negative risk:  704 706 1088 1142 365 385 102 91 163 132 71 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
101 
disease_progression 
H-positive risk:  707 711 94 1139 385 102 1083 362 132 52 163 70 
H-negative risk:  711 707 1083 1139 362 385 102 94 163 132 70 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 102 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
102 
disease_progression 
H-positive risk:  710 714 91 1135 383 101 1089 359 131 51 166 70 
H-negative risk:  714 710 1089 1135 359 383 101 91 166 131 70 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 102 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
103 
disease_progression 
H-positive risk:  720 712 91 1133 383 100 1084 360 132 52 165 68 
H-negative risk:  712 720 1084 1133 360 383 100 91 165 132 68 52 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 102 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
104 
disease_progression 
H-positive risk:  716 710 91 1128 384 99 1092 361 131 56 166 66 
H-negative risk:  710 716 1092 1128 361 384 99 91 166 131 66 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 104 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
105 
disease_progression 
H-positive risk:  727 717 92 1115 390 99 1089 358 129 56 165 63 
H-negative risk:  717 727 1089 1115 358 390 99 92 165 129 63 56 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 103 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
106 
disease_progression 
H-positive risk:  731 717 93 1117 393 99 1079 362 127 56 165 61 
H-negative risk:  717 731 1079 1117 362 393 99 93 165 127 61 56 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 109 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
107 
disease_progression 
H-positive risk:  742 720 94 1120 389 101 1067 362 126 56 164 59 
H-negative risk:  720 742 1067 1120 362 389 101 94 164 126 59 56 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 107 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
108 
disease_progression 
H-positive risk:  736 724 98 1116 391 100 1075 354 127 56 165 58 
H-negative risk:  724 736 1075 1116 354 391 100 98 165 127 58 56 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 107 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
109 
disease_progression 
H-positive risk:  680 674 91 1165 395 92 1129 362 134 54 166 58 
H-negative risk:  674 680 1129 1165 362 395 92 91 166 134 58 54 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 109 23 

clinical_engagement 
diagnosis 
demography 
99 new agents 
110 
disease_progression 
H-positive risk:  681 682 91 1145 401 89 1113 387 133 55 164 59 
H-negative risk:  682 681 1113 1145 387 401 89 91 164 133 59 55 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 110 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
111 
disease_progression 
H-positive risk:  672 680 92 1151 396 86 1111 399 133 55 161 64 
H-negative risk:  680 672 1111 1151 399 396 86 92 161 133 64 55 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 105 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
112 
disease_progression 
H-positive risk:  666 687 92 1141 400 88 1115 399 133 55 160 64 
H-negative risk:  687 666 1115 1141 399 400 88 92 160 133 64 55 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 106 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
113 
disease_progression 
H-positive risk:  664 692 92 1144 398 88 1108 404 134 54 157 65 
H-negative risk:  692 664 1108 1144 404 398 88 92 157 134 65 54 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 107 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
114 
disease_progression 
H-positive risk:  665 692 93 1138 398 91 1105 405 139 53 159 62 
H-negative risk:  692 665 1105 1138 405 398 91 93 159 139 62 53 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 106 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
115 
disease_progression 
H-positive risk:  663 698 94 1131 399 92 1108 403 136 55 158 63 
H-negative risk:  698 663 1108 1131 403 399 92 94 158 136 63 55 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 111 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
116 
disease_progression 
H-positive risk:  664 705 95 1130 397 91 1103 404 135 54 159 63 
H-negative risk:  705 664 1103 1130 404 397 91 95 159 135 63 54 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 108 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
117 
disease_progression 
H-positive risk:  658 709 95 1142 394 92 1102 394 140 53 160 61 
H-negative risk:  709 658 1102 1142 394 394 92 95 160 140 61 53 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 106 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
118 
disease_progression 
H-positive risk:  661 707 98 1149 385 91 1097 392 144 54 161 61 
H-negative risk:  707 661 1097 1149 392 385 91 98 161 144 61 54 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
119 
disease_progression 
H-positive risk:  668 721 98 1133 384 95 1088 394 145 53 159 62 
H-negative risk:  721 668 1088 1133 394 384 95 98 159 145 62 53 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
120 
disease_progression 
H-positive risk:  673 725 97 1136 381 94 1084 391 145 55 158 61 
H-negative risk:  725 673 1084 1136 391 381 94 97 158 145 61 55 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 102 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
121 
disease_progression 
H-positive risk:  636 683 95 1174 380 87 1132 393 150 54 158 58 
H-negative risk:  683 636 1132 1174 393 380 87 95 158 150 58 54 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 105 25 

clinical_engagement 
diagnosis 
demography 
102 new agents 
122 
disease_progression 
H-positive risk:  638 680 95 1176 383 88 1126 395 149 52 163 55 
H-negative risk:  680 638 1126 1176 395 383 88 95 163 149 55 52 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 103 29 

clinical_engagement 
diagnosis 
demography 
85 new agents 
123 
disease_progression 
H-positive risk:  634 683 98 1173 386 89 1116 397 150 54 162 58 
H-negative risk:  683 634 1116 1173 397 386 89 98 162 150 58 54 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 101 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
124 
disease_progression 
H-positive risk:  634 691 97 1171 376 86 1122 396 151 53 162 61 
H-negative risk:  691 634 1122 1171 396 376 86 97 162 151 61 53 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 99 33 

clinical_engagement 
diagnosis 
demography 
54 new agents 
125 
disease_progression 
H-positive risk:  629 682 96 1165 383 87 1123 406 153 53 158 65 
H-negative risk:  682 629 1123 1165 406 383 87 96 158 153 65 53 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 98 34 

clinical_engagement 
diagnosis 
demography 
62 new agents 
126 
disease_progression 
H-positive risk:  628 679 95 1175 382 86 1126 400 154 53 155 67 
H-negative risk:  679 628 1126 1175 400 382 86 95 155 154 67 53 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 98 34 

clinical_engagement 
diagnosis 
demography 
67 new agents 
127 
disease_progression 
H-positive risk:  622 679 94 1173 379 86 1129 398 157 57 158 68 
H-negative risk:  679 622 1129 1173 398 379 86 94 158 157 68 57 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 99 33 

clinical_engagement 
diagnosis 
demography 
87 new agents 
128 
disease_progression 
H-positive risk:  625 677 93 1175 387 84 1131 389 158 54 160 67 
H-negative risk:  677 625 1131 1175 389 387 84 93 160 158 67 54 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 95 35 

clinical_engagement 
diagnosis 
demography 
68 new agents 
129 
disease_progression 
H-positive risk:  621 683 96 1173 379 84 1134 393 159 53 159 66 
H-negative risk:  683 621 1134 1173 393 379 84 96 159 159 66 53 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 99 34 

clinical_engagement 
diagnosis 
demography 
71 new agents 
130 
disease_progression 
H-positive risk:  625 683 96 1166 374 85 1135 398 161 53 158 66 
H-negative risk:  683 625 1135 1166 398 374 85 96 158 161 66 53 
New BC onsets:  137
BC status:  4863 137 
BC subtype:  4863 103 34 

clinical_engagement 
diagnosis 
demography 
71 new agents 
131 
disease_progression 
H-positive risk:  624 681 97 1168 369 87 1143 397 162 51 155 66 
H-negative risk:  681 624 1143 1168 397 369 87 97 155 162 66 51 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 102 33 

clinical_engagement 
diagnosis 
demography 
84 new agents 
132 
disease_progression 
H-positive risk:  628 683 99 1167 370 87 1141 397 159 50 154 65 
H-negative risk:  683 628 1141 1167 397 370 87 99 154 159 65 50 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 103 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
133 
disease_progression 
H-positive risk:  631 676 101 1167 372 90 1143 394 159 49 154 64 
H-negative risk:  676 631 1143 1167 394 372 90 101 154 159 64 49 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 102 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
134 
disease_progression 
H-positive risk:  621 675 102 1171 373 89 1135 413 162 48 147 64 
H-negative risk:  675 621 1135 1171 413 373 89 102 147 162 64 48 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 101 33 

clinical_engagement 
diagnosis 
demography 
63 new agents 
135 
disease_progression 
H-positive risk:  626 667 102 1180 374 90 1130 411 158 51 149 62 
H-negative risk:  667 626 1130 1180 411 374 90 102 149 158 62 51 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 100 34 

clinical_engagement 
diagnosis 
demography 
61 new agents 
136 
disease_progression 
H-positive risk:  621 667 99 1177 381 91 1135 410 156 50 148 65 
H-negative risk:  667 621 1135 1177 410 381 91 99 148 156 65 50 
New BC onsets:  138
BC status:  4862 138 
BC subtype:  4862 104 34 

clinical_engagement 
diagnosis 
demography 
71 new agents 
137 
disease_progression 
H-positive risk:  625 667 100 1179 374 91 1133 411 156 48 152 64 
H-negative risk:  667 625 1133 1179 411 374 91 100 152 156 64 48 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 99 35 

clinical_engagement 
diagnosis 
demography 
72 new agents 
138 
disease_progression 
H-positive risk:  629 671 99 1179 375 88 1129 405 161 47 155 62 
H-negative risk:  671 629 1129 1179 405 375 88 99 155 161 62 47 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 98 35 

clinical_engagement 
diagnosis 
demography 
82 new agents 
139 
disease_progression 
H-positive risk:  637 680 99 1172 374 91 1131 400 158 46 154 58 
H-negative risk:  680 637 1131 1172 400 374 91 99 154 158 58 46 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 99 35 

clinical_engagement 
diagnosis 
demography 
75 new agents 
140 
disease_progression 
H-positive risk:  635 679 100 1176 376 93 1126 403 157 49 149 57 
H-negative risk:  679 635 1126 1176 403 376 93 100 149 157 57 49 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 96 38 

clinical_engagement 
diagnosis 
demography 
67 new agents 
141 
disease_progression 
H-positive risk:  639 677 100 1181 373 93 1130 403 155 46 145 58 
H-negative risk:  677 639 1130 1181 403 373 93 100 145 155 58 46 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 96 37 

clinical_engagement 
diagnosis 
demography 
69 new agents 
142 
disease_progression 
H-positive risk:  639 679 100 1171 376 95 1124 407 158 46 145 60 
H-negative risk:  679 639 1124 1171 407 376 95 100 145 158 60 46 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 96 38 

clinical_engagement 
diagnosis 
demography 
80 new agents 
143 
disease_progression 
H-positive risk:  646 681 100 1169 373 94 1123 404 154 48 144 64 
H-negative risk:  681 646 1123 1169 404 373 94 100 144 154 64 48 
New BC onsets:  137
BC status:  4863 137 
BC subtype:  4863 99 38 

clinical_engagement 
diagnosis 
demography 
62 new agents 
144 
disease_progression 
H-positive risk:  640 672 98 1176 373 91 1133 403 154 50 146 64 
H-negative risk:  672 640 1133 1176 403 373 91 98 146 154 64 50 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 99 37 

clinical_engagement 
diagnosis 
demography 
66 new agents 
145 
disease_progression 
H-positive risk:  647 672 94 1171 375 93 1131 401 152 48 150 66 
H-negative risk:  672 647 1131 1171 401 375 93 94 150 152 66 48 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 97 38 

clinical_engagement 
diagnosis 
demography 
86 new agents 
146 
disease_progression 
H-positive risk:  643 672 93 1159 386 93 1120 416 156 46 151 65 
H-negative risk:  672 643 1120 1159 416 386 93 93 151 156 65 46 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 100 36 

clinical_engagement 
diagnosis 
demography 
69 new agents 
147 
disease_progression 
H-positive risk:  645 664 95 1156 387 91 1127 418 156 45 152 64 
H-negative risk:  664 645 1127 1156 418 387 91 95 152 156 64 45 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 100 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
148 
disease_progression 
H-positive risk:  646 659 96 1145 399 92 1129 415 157 47 149 66 
H-negative risk:  659 646 1129 1145 415 399 92 96 149 157 66 47 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 100 33 

clinical_engagement 
diagnosis 
demography 
70 new agents 
149 
disease_progression 
H-positive risk:  646 665 98 1146 398 93 1118 413 157 48 149 69 
H-negative risk:  665 646 1118 1146 413 398 93 98 149 157 69 48 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 102 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
150 
disease_progression 
H-positive risk:  647 664 96 1143 401 97 1120 414 153 50 152 63 
H-negative risk:  664 647 1120 1143 414 401 97 96 152 153 63 50 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 101 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
151 
disease_progression 
H-positive risk:  645 672 91 1146 402 95 1122 409 152 49 152 65 
H-negative risk:  672 645 1122 1146 409 402 95 91 152 152 65 49 
New BC onsets:  137
BC status:  4863 137 
BC subtype:  4863 102 35 

clinical_engagement 
diagnosis 
demography 
79 new agents 
152 
disease_progression 
H-positive risk:  648 664 93 1146 400 96 1131 410 149 49 150 64 
H-negative risk:  664 648 1131 1146 410 400 96 93 150 149 64 49 
New BC onsets:  137
BC status:  4863 137 
BC subtype:  4863 103 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
153 
disease_progression 
H-positive risk:  651 675 90 1146 400 97 1130 401 148 49 148 65 
H-negative risk:  675 651 1130 1146 401 400 97 90 148 148 65 49 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 98 34 

clinical_engagement 
diagnosis 
demography 
76 new agents 
154 
disease_progression 
H-positive risk:  651 672 92 1134 408 97 1136 404 146 51 147 62 
H-negative risk:  672 651 1136 1134 404 408 97 92 147 146 62 51 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 97 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  652 671 93 1138 403 98 1136 401 149 51 146 62 
H-negative risk:  671 652 1136 1138 401 403 98 93 146 149 62 51 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 95 37 

clinical_engagement 
diagnosis 
demography 
65 new agents 
156 
disease_progression 
H-positive risk:  656 668 92 1139 398 100 1128 410 151 53 146 59 
H-negative risk:  668 656 1128 1139 410 398 100 92 146 151 59 53 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 95 36 

clinical_engagement 
diagnosis 
demography 
75 new agents 
157 
disease_progression 
H-positive risk:  654 671 98 1145 394 100 1128 405 148 54 145 58 
H-negative risk:  671 654 1128 1145 405 394 100 98 145 148 58 54 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 91 36 

clinical_engagement 
diagnosis 
demography 
76 new agents 
158 
disease_progression 
H-positive risk:  653 669 98 1134 403 98 1124 414 148 57 145 57 
H-negative risk:  669 653 1124 1134 414 403 98 98 145 148 57 57 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 92 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
159 
disease_progression 
H-positive risk:  661 675 97 1122 408 100 1116 414 147 56 144 60 
H-negative risk:  675 661 1116 1122 414 408 100 97 144 147 60 56 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 90 35 

clinical_engagement 
diagnosis 
demography 
72 new agents 
160 
disease_progression 
H-positive risk:  664 675 96 1123 409 98 1114 415 145 57 142 62 
H-negative risk:  675 664 1114 1123 415 409 98 96 142 145 62 57 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 90 35 

clinical_engagement 
diagnosis 
demography 
64 new agents 
161 
disease_progression 
H-positive risk:  672 672 96 1121 410 98 1109 415 142 59 145 61 
H-negative risk:  672 672 1109 1121 415 410 98 96 145 142 61 59 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 90 35 

clinical_engagement 
diagnosis 
demography 
75 new agents 
162 
disease_progression 
H-positive risk:  672 673 93 1119 409 98 1114 417 143 57 144 61 
H-negative risk:  673 672 1114 1119 417 409 98 93 144 143 61 57 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 89 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
163 
disease_progression 
H-positive risk:  672 671 91 1118 416 96 1109 416 143 57 147 64 
H-negative risk:  671 672 1109 1118 416 416 96 91 147 143 64 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 87 32 

clinical_engagement 
diagnosis 
demography 
91 new agents 
164 
disease_progression 
H-positive risk:  674 671 91 1121 415 91 1114 413 143 55 149 63 
H-negative risk:  671 674 1114 1121 413 415 91 91 149 143 63 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 87 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
165 
disease_progression 
H-positive risk:  679 657 90 1138 416 92 1117 407 139 55 148 62 
H-negative risk:  657 679 1117 1138 407 416 92 90 148 139 62 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 86 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
166 
disease_progression 
H-positive risk:  682 655 90 1145 407 92 1118 406 140 54 149 62 
H-negative risk:  655 682 1118 1145 406 407 92 90 149 140 62 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 84 35 

clinical_engagement 
diagnosis 
demography 
90 new agents 
167 
disease_progression 
H-positive risk:  689 656 93 1157 392 91 1118 397 145 53 150 59 
H-negative risk:  656 689 1118 1157 397 392 91 93 150 145 59 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 86 35 

clinical_engagement 
diagnosis 
demography 
54 new agents 
168 
disease_progression 
H-positive risk:  688 654 92 1153 398 89 1125 393 143 54 154 57 
H-negative risk:  654 688 1125 1153 393 398 89 92 154 143 57 54 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
169 
disease_progression 
H-positive risk:  683 653 89 1149 398 90 1131 390 143 58 158 58 
H-negative risk:  653 683 1131 1149 390 398 90 89 158 143 58 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
100 new agents 
170 
disease_progression 
H-positive risk:  687 672 93 1144 395 89 1108 396 142 58 155 61 
H-negative risk:  672 687 1108 1144 396 395 89 93 155 142 61 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
83 new agents 
171 
disease_progression 
H-positive risk:  688 675 91 1131 404 88 1115 395 143 58 156 56 
H-negative risk:  675 688 1115 1131 395 404 88 91 156 143 56 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
172 
disease_progression 
H-positive risk:  694 671 92 1142 399 85 1112 395 146 55 155 54 
H-negative risk:  671 694 1112 1142 395 399 85 92 155 146 54 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 88 33 

clinical_engagement 
diagnosis 
demography 
91 new agents 
173 
disease_progression 
H-positive risk:  693 674 93 1149 386 86 1113 400 142 57 156 51 
H-negative risk:  674 693 1113 1149 400 386 86 93 156 142 51 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 87 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
174 
disease_progression 
H-positive risk:  691 679 93 1144 388 86 1111 400 140 57 160 51 
H-negative risk:  679 691 1111 1144 400 388 86 93 160 140 51 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
175 
disease_progression 
H-positive risk:  686 673 92 1145 383 86 1118 407 139 57 166 48 
H-negative risk:  673 686 1118 1145 407 383 86 92 166 139 48 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
176 
disease_progression 
H-positive risk:  696 662 95 1153 380 87 1114 400 142 56 164 51 
H-negative risk:  662 696 1114 1153 400 380 87 95 164 142 51 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
177 
disease_progression 
H-positive risk:  690 664 93 1165 365 84 1119 407 145 57 161 50 
H-negative risk:  664 690 1119 1165 407 365 84 93 161 145 50 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
178 
disease_progression 
H-positive risk:  683 670 95 1160 369 85 1119 407 143 57 160 52 
H-negative risk:  670 683 1119 1160 407 369 85 95 160 143 52 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
179 
disease_progression 
H-positive risk:  689 668 94 1152 368 85 1127 403 142 56 163 53 
H-negative risk:  668 689 1127 1152 403 368 85 94 163 142 53 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
52 new agents 
180 
disease_progression 
H-positive risk:  686 669 95 1158 367 84 1126 407 139 56 163 50 
H-negative risk:  669 686 1126 1158 407 367 84 95 163 139 50 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
181 
disease_progression 
H-positive risk:  695 665 98 1154 373 81 1124 402 139 53 163 53 
H-negative risk:  665 695 1124 1154 402 373 81 98 163 139 53 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
182 
disease_progression 
H-positive risk:  702 662 98 1151 387 83 1125 393 133 49 160 57 
H-negative risk:  662 702 1125 1151 393 387 83 98 160 133 57 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
183 
disease_progression 
H-positive risk:  704 661 98 1156 388 81 1122 395 133 45 163 54 
H-negative risk:  661 704 1122 1156 395 388 81 98 163 133 54 45 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
184 
disease_progression 
H-positive risk:  700 662 98 1153 387 79 1130 398 129 46 162 56 
H-negative risk:  662 700 1130 1153 398 387 79 98 162 129 56 46 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
185 
disease_progression 
H-positive risk:  705 661 98 1151 391 80 1116 405 131 44 164 54 
H-negative risk:  661 705 1116 1151 405 391 80 98 164 131 54 44 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
186 
disease_progression 
H-positive risk:  702 672 96 1149 389 81 1111 400 135 45 165 55 
H-negative risk:  672 702 1111 1149 400 389 81 96 165 135 55 45 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
187 
disease_progression 
H-positive risk:  704 670 96 1145 391 80 1107 401 139 46 167 54 
H-negative risk:  670 704 1107 1145 401 391 80 96 167 139 54 46 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
188 
disease_progression 
H-positive risk:  704 666 97 1137 392 83 1110 406 138 47 167 53 
H-negative risk:  666 704 1110 1137 406 392 83 97 167 138 53 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
189 
disease_progression 
H-positive risk:  705 673 96 1130 390 86 1103 410 139 47 166 55 
H-negative risk:  673 705 1103 1130 410 390 86 96 166 139 55 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
190 
disease_progression 
H-positive risk:  700 679 97 1121 389 88 1106 412 141 47 167 53 
H-negative risk:  679 700 1106 1121 412 389 88 97 167 141 53 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
191 
disease_progression 
H-positive risk:  693 676 98 1134 385 89 1102 417 140 48 165 53 
H-negative risk:  676 693 1102 1134 417 385 89 98 165 140 53 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
192 
disease_progression 
H-positive risk:  700 681 95 1131 381 93 1093 421 138 48 167 52 
H-negative risk:  681 700 1093 1131 421 381 93 95 167 138 52 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
193 
disease_progression 
H-positive risk:  691 677 96 1128 387 96 1098 423 137 49 164 54 
H-negative risk:  677 691 1098 1128 423 387 96 96 164 137 54 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
94 new agents 
194 
disease_progression 
H-positive risk:  700 678 97 1128 397 96 1082 418 141 49 162 52 
H-negative risk:  678 700 1082 1128 418 397 96 97 162 141 52 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
195 
disease_progression 
H-positive risk:  700 676 93 1133 398 93 1083 410 144 51 162 57 
H-negative risk:  676 700 1083 1133 410 398 93 93 162 144 57 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
196 
disease_progression 
H-positive risk:  706 672 91 1131 399 94 1089 406 143 49 164 56 
H-negative risk:  672 706 1089 1131 406 399 94 91 164 143 56 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
197 
disease_progression 
H-positive risk:  702 675 92 1123 400 93 1091 413 144 47 163 57 
H-negative risk:  675 702 1091 1123 413 400 93 92 163 144 57 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
198 
disease_progression 
H-positive risk:  693 673 94 1122 403 95 1098 411 142 48 162 59 
H-negative risk:  673 693 1098 1122 411 403 95 94 162 142 59 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
199 
disease_progression 
H-positive risk:  695 666 94 1126 411 96 1087 413 144 47 164 57 
H-negative risk:  666 695 1087 1126 413 411 96 94 164 144 57 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
200 
disease_progression 
H-positive risk:  705 670 94 1127 411 94 1079 413 143 50 160 54 
H-negative risk:  670 705 1079 1127 413 411 94 94 160 143 54 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
201 
disease_progression 
H-positive risk:  699 662 95 1130 411 93 1091 408 142 50 163 56 
H-negative risk:  662 699 1091 1130 408 411 93 95 163 142 56 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
202 
disease_progression 
H-positive risk:  708 668 93 1124 415 95 1074 407 145 50 162 59 
H-negative risk:  668 708 1074 1124 407 415 95 93 162 145 59 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
203 
disease_progression 
H-positive risk:  701 665 92 1125 412 97 1072 415 145 51 167 58 
H-negative risk:  665 701 1072 1125 415 412 97 92 167 145 58 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
204 
disease_progression 
H-positive risk:  703 660 92 1124 416 98 1075 415 143 52 167 55 
H-negative risk:  660 703 1075 1124 415 416 98 92 167 143 55 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
205 
disease_progression 
H-positive risk:  706 667 94 1113 410 95 1086 412 145 52 166 54 
H-negative risk:  667 706 1086 1113 412 410 95 94 166 145 54 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
101 new agents 
206 
disease_progression 
H-positive risk:  705 667 96 1101 414 88 1091 420 148 51 158 61 
H-negative risk:  667 705 1091 1101 420 414 88 96 158 148 61 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
207 
disease_progression 
H-positive risk:  696 668 98 1100 413 88 1095 423 146 55 155 63 
H-negative risk:  668 696 1095 1100 423 413 88 98 155 146 63 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
208 
disease_progression 
H-positive risk:  700 656 99 1103 421 90 1089 425 144 55 156 62 
H-negative risk:  656 700 1089 1103 425 421 90 99 156 144 62 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
209 
disease_progression 
H-positive risk:  698 656 98 1110 419 92 1083 432 143 54 156 59 
H-negative risk:  656 698 1083 1110 432 419 92 98 156 143 59 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
210 
disease_progression 
H-positive risk:  710 659 99 1118 408 92 1076 428 145 53 153 59 
H-negative risk:  659 710 1076 1118 428 408 92 99 153 145 59 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
211 
disease_progression 
H-positive risk:  713 656 101 1114 406 92 1079 429 144 53 153 60 
H-negative risk:  656 713 1079 1114 429 406 92 101 153 144 60 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
212 
disease_progression 
H-positive risk:  712 654 101 1115 399 93 1083 427 147 55 152 62 
H-negative risk:  654 712 1083 1115 427 399 93 101 152 147 62 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
213 
disease_progression 
H-positive risk:  708 659 98 1113 394 93 1082 432 147 55 158 61 
H-negative risk:  659 708 1082 1113 432 394 93 98 158 147 61 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
214 
disease_progression 
H-positive risk:  707 649 100 1117 398 95 1078 431 145 59 158 63 
H-negative risk:  649 707 1078 1117 431 398 95 100 158 145 63 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
215 
disease_progression 
H-positive risk:  702 663 98 1119 396 92 1075 425 150 57 153 70 
H-negative risk:  663 702 1075 1119 425 396 92 98 153 150 70 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
216 
disease_progression 
H-positive risk:  702 662 102 1125 397 90 1075 421 148 57 148 73 
H-negative risk:  662 702 1075 1125 421 397 90 102 148 148 73 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
217 
disease_progression 
H-positive risk:  701 667 100 1117 398 92 1074 423 147 59 146 76 
H-negative risk:  667 701 1074 1117 423 398 92 100 146 147 76 59 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
218 
disease_progression 
H-positive risk:  705 668 100 1120 403 92 1069 418 150 54 145 76 
H-negative risk:  668 705 1069 1120 418 403 92 100 145 150 76 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
219 
disease_progression 
H-positive risk:  696 669 104 1123 399 92 1076 416 147 58 145 75 
H-negative risk:  669 696 1076 1123 416 399 92 104 145 147 75 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
96 new agents 
220 
disease_progression 
H-positive risk:  692 674 104 1128 403 91 1079 412 142 56 144 75 
H-negative risk:  674 692 1079 1128 412 403 91 104 144 142 75 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
221 
disease_progression 
H-positive risk:  700 677 102 1123 404 91 1069 413 143 54 148 76 
H-negative risk:  677 700 1069 1123 413 404 91 102 148 143 76 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
222 
disease_progression 
H-positive risk:  690 682 104 1121 410 86 1066 410 149 57 148 77 
H-negative risk:  682 690 1066 1121 410 410 86 104 148 149 77 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
223 
disease_progression 
H-positive risk:  689 677 102 1127 411 85 1064 412 151 54 150 78 
H-negative risk:  677 689 1064 1127 412 411 85 102 150 151 78 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
224 
disease_progression 
H-positive risk:  678 679 102 1123 412 86 1071 416 151 52 152 78 
H-negative risk:  679 678 1071 1123 416 412 86 102 152 151 78 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
225 
disease_progression 
H-positive risk:  670 682 104 1128 410 88 1073 417 151 50 153 74 
H-negative risk:  682 670 1073 1128 417 410 88 104 153 151 74 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
226 
disease_progression 
H-positive risk:  669 686 101 1123 411 92 1060 426 155 49 154 74 
H-negative risk:  686 669 1060 1123 426 411 92 101 154 155 74 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
227 
disease_progression 
H-positive risk:  673 688 101 1120 411 93 1064 417 155 52 155 71 
H-negative risk:  688 673 1064 1120 417 411 93 101 155 155 71 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
228 
disease_progression 
H-positive risk:  671 688 99 1126 412 91 1062 413 157 51 159 71 
H-negative risk:  688 671 1062 1126 413 412 91 99 159 157 71 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
229 
disease_progression 
H-positive risk:  673 693 100 1106 429 87 1047 427 153 57 156 72 
H-negative risk:  693 673 1047 1106 427 429 87 100 156 153 72 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 100 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
230 
disease_progression 
H-positive risk:  664 692 100 1101 429 87 1054 432 153 59 158 71 
H-negative risk:  692 664 1054 1101 432 429 87 100 158 153 71 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 98 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
231 
disease_progression 
H-positive risk:  663 688 101 1110 419 89 1053 442 153 59 157 66 
H-negative risk:  688 663 1053 1110 442 419 89 101 157 153 66 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
232 
disease_progression 
H-positive risk:  661 681 104 1112 421 88 1051 447 155 61 156 63 
H-negative risk:  681 661 1051 1112 447 421 88 104 156 155 63 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 98 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
233 
disease_progression 
H-positive risk:  654 680 105 1117 419 89 1054 446 157 61 155 63 
H-negative risk:  680 654 1054 1117 446 419 89 105 155 157 63 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
234 
disease_progression 
H-positive risk:  651 683 104 1124 418 89 1062 435 155 66 152 61 
H-negative risk:  683 651 1062 1124 435 418 89 104 152 155 61 66 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
235 
disease_progression 
H-positive risk:  652 689 104 1111 422 90 1056 438 157 67 154 60 
H-negative risk:  689 652 1056 1111 438 422 90 104 154 157 60 67 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
236 
disease_progression 
H-positive risk:  647 678 102 1112 434 92 1065 441 148 68 155 58 
H-negative risk:  678 647 1065 1112 441 434 92 102 155 148 58 68 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
237 
disease_progression 
H-positive risk:  648 676 106 1110 441 90 1065 436 148 69 153 58 
H-negative risk:  676 648 1065 1110 436 441 90 106 153 148 58 69 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
238 
disease_progression 
H-positive risk:  654 687 101 1098 442 86 1065 436 152 68 155 56 
H-negative risk:  687 654 1065 1098 436 442 86 101 155 152 56 68 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 98 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
239 
disease_progression 
H-positive risk:  660 685 101 1103 434 87 1060 435 153 68 156 58 
H-negative risk:  685 660 1060 1103 435 434 87 101 156 153 58 68 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
240 
disease_progression 
H-positive risk:  656 689 99 1102 436 89 1064 430 153 69 157 56 
H-negative risk:  689 656 1064 1102 430 436 89 99 157 153 56 69 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
241 
disease_progression 
H-positive risk:  649 691 99 1094 447 86 1058 442 152 68 157 57 
H-negative risk:  691 649 1058 1094 442 447 86 99 157 152 57 68 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 99 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
242 
disease_progression 
H-positive risk:  640 692 98 1107 441 85 1055 447 150 66 159 60 
H-negative risk:  692 640 1055 1107 447 441 85 98 159 150 60 66 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 100 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
243 
disease_progression 
H-positive risk:  649 693 95 1099 438 84 1057 440 155 68 161 61 
H-negative risk:  693 649 1057 1099 440 438 84 95 161 155 61 68 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 99 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
244 
disease_progression 
H-positive risk:  657 692 92 1104 433 82 1052 443 157 67 162 59 
H-negative risk:  692 657 1052 1104 443 433 82 92 162 157 59 67 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 105 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
245 
disease_progression 
H-positive risk:  663 689 92 1110 433 82 1050 437 156 66 165 57 
H-negative risk:  689 663 1050 1110 437 433 82 92 165 156 57 66 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 105 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
246 
disease_progression 
H-positive risk:  671 676 92 1116 428 81 1044 444 158 65 165 60 
H-negative risk:  676 671 1044 1116 444 428 81 92 165 158 60 65 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 105 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
247 
disease_progression 
H-positive risk:  669 684 98 1122 414 79 1035 452 158 63 165 61 
H-negative risk:  684 669 1035 1122 452 414 79 98 165 158 61 63 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 109 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
248 
disease_progression 
H-positive risk:  670 682 97 1120 411 81 1043 450 158 63 164 61 
H-negative risk:  682 670 1043 1120 450 411 81 97 164 158 61 63 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 107 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
249 
disease_progression 
H-positive risk:  671 693 96 1119 407 80 1034 451 161 64 166 58 
H-negative risk:  693 671 1034 1119 451 407 80 96 166 161 58 64 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 106 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
250 
disease_progression 
H-positive risk:  667 693 97 1119 407 81 1031 455 162 64 166 58 
H-negative risk:  693 667 1031 1119 455 407 81 97 166 162 58 64 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
251 
disease_progression 
H-positive risk:  661 684 98 1128 410 80 1043 447 163 63 164 59 
H-negative risk:  684 661 1043 1128 447 410 80 98 164 163 59 63 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 106 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
252 
disease_progression 
H-positive risk:  663 691 98 1129 413 79 1048 428 163 64 166 58 
H-negative risk:  691 663 1048 1129 428 413 79 98 166 163 58 64 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
253 
disease_progression 
H-positive risk:  664 696 96 1126 414 80 1046 428 165 60 169 56 
H-negative risk:  696 664 1046 1126 428 414 80 96 169 165 56 60 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 101 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
254 
disease_progression 
H-positive risk:  662 679 95 1139 419 82 1050 420 163 61 175 55 
H-negative risk:  679 662 1050 1139 420 419 82 95 175 163 55 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 100 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
255 
disease_progression 
H-positive risk:  662 671 97 1142 426 82 1049 418 161 61 174 57 
H-negative risk:  671 662 1049 1142 418 426 82 97 174 161 57 61 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
256 
disease_progression 
H-positive risk:  659 681 97 1132 433 81 1052 417 161 60 173 54 
H-negative risk:  681 659 1052 1132 417 433 81 97 173 161 54 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
257 
disease_progression 
H-positive risk:  663 679 95 1126 442 79 1051 416 162 59 172 56 
H-negative risk:  679 663 1051 1126 416 442 79 95 172 162 56 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
258 
disease_progression 
H-positive risk:  672 673 96 1132 440 82 1047 413 160 58 171 56 
H-negative risk:  673 672 1047 1132 413 440 82 96 171 160 56 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
259 
disease_progression 
H-positive risk:  665 685 95 1125 443 79 1044 418 155 62 172 57 
H-negative risk:  685 665 1044 1125 418 443 79 95 172 155 57 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
260 
disease_progression 
H-positive risk:  668 685 97 1118 442 80 1049 416 153 65 171 56 
H-negative risk:  685 668 1049 1118 416 442 80 97 171 153 56 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
261 
disease_progression 
H-positive risk:  670 688 97 1120 438 77 1049 412 157 63 173 56 
H-negative risk:  688 670 1049 1120 412 438 77 97 173 157 56 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
262 
disease_progression 
H-positive risk:  672 691 98 1119 432 77 1048 410 159 64 173 57 
H-negative risk:  691 672 1048 1119 410 432 77 98 173 159 57 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
263 
disease_progression 
H-positive risk:  674 692 97 1116 431 78 1055 408 159 63 170 57 
H-negative risk:  692 674 1055 1116 408 431 78 97 170 159 57 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
264 
disease_progression 
H-positive risk:  669 693 95 1121 436 76 1056 405 160 64 167 58 
H-negative risk:  693 669 1056 1121 405 436 76 95 167 160 58 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
265 
disease_progression 
H-positive risk:  681 695 96 1124 425 78 1050 405 159 63 168 56 
H-negative risk:  695 681 1050 1124 405 425 78 96 168 159 56 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
266 
disease_progression 
H-positive risk:  687 691 97 1119 430 78 1049 411 160 59 163 56 
H-negative risk:  691 687 1049 1119 411 430 78 97 163 160 56 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
267 
disease_progression 
H-positive risk:  692 687 99 1114 432 79 1053 412 160 56 162 54 
H-negative risk:  687 692 1053 1114 412 432 79 99 162 160 54 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
268 
disease_progression 
H-positive risk:  690 686 96 1118 426 80 1064 407 163 57 162 51 
H-negative risk:  686 690 1064 1118 407 426 80 96 162 163 51 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
269 
disease_progression 
H-positive risk:  697 687 96 1107 427 77 1060 417 162 57 160 53 
H-negative risk:  687 697 1060 1107 417 427 77 96 160 162 53 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
270 
disease_progression 
H-positive risk:  690 680 92 1115 421 79 1070 417 161 59 162 54 
H-negative risk:  680 690 1070 1115 417 421 79 92 162 161 54 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
271 
disease_progression 
H-positive risk:  690 675 93 1122 409 82 1066 424 158 62 163 56 
H-negative risk:  675 690 1066 1122 424 409 82 93 163 158 56 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
272 
disease_progression 
H-positive risk:  690 672 95 1119 408 80 1076 420 161 59 163 57 
H-negative risk:  672 690 1076 1119 420 408 80 95 163 161 57 59 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
273 
disease_progression 
H-positive risk:  689 677 95 1111 413 81 1083 421 160 55 159 56 
H-negative risk:  677 689 1083 1111 421 413 81 95 159 160 56 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
97 new agents 
274 
disease_progression 
H-positive risk:  698 686 94 1096 412 83 1076 424 159 54 159 59 
H-negative risk:  686 698 1076 1096 424 412 83 94 159 159 59 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
275 
disease_progression 
H-positive risk:  708 687 93 1093 410 83 1078 416 157 56 161 58 
H-negative risk:  687 708 1078 1093 416 410 83 93 161 157 58 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
276 
disease_progression 
H-positive risk:  705 686 94 1090 405 84 1087 418 153 59 159 60 
H-negative risk:  686 705 1087 1090 418 405 84 94 159 153 60 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
277 
disease_progression 
H-positive risk:  698 689 93 1097 402 85 1086 420 155 56 161 58 
H-negative risk:  689 698 1086 1097 420 402 85 93 161 155 58 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
278 
disease_progression 
H-positive risk:  696 690 95 1103 396 83 1085 420 152 58 160 62 
H-negative risk:  690 696 1085 1103 420 396 83 95 160 152 62 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
279 
disease_progression 
H-positive risk:  703 695 96 1099 389 85 1085 421 149 58 159 61 
H-negative risk:  695 703 1085 1099 421 389 85 96 159 149 61 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
280 
disease_progression 
H-positive risk:  698 698 95 1097 393 87 1091 414 147 60 159 61 
H-negative risk:  698 698 1091 1097 414 393 87 95 159 147 61 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
281 
disease_progression 
H-positive risk:  698 692 95 1104 393 86 1096 414 146 59 156 61 
H-negative risk:  692 698 1096 1104 414 393 86 95 156 146 61 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
282 
disease_progression 
H-positive risk:  698 687 96 1097 393 89 1098 416 148 62 155 61 
H-negative risk:  687 698 1098 1097 416 393 89 96 155 148 61 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
283 
disease_progression 
H-positive risk:  702 689 94 1100 394 90 1092 417 147 61 152 62 
H-negative risk:  689 702 1092 1100 417 394 90 94 152 147 62 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
284 
disease_progression 
H-positive risk:  703 690 89 1107 391 92 1088 420 144 64 150 62 
H-negative risk:  690 703 1088 1107 420 391 92 89 150 144 62 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
285 
disease_progression 
H-positive risk:  698 689 87 1107 387 90 1094 424 149 63 150 62 
H-negative risk:  689 698 1094 1107 424 387 90 87 150 149 62 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
286 
disease_progression 
H-positive risk:  689 681 87 1111 382 92 1106 427 146 65 150 64 
H-negative risk:  681 689 1106 1111 427 382 92 87 150 146 64 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
287 
disease_progression 
H-positive risk:  689 684 86 1110 381 93 1112 424 148 59 151 63 
H-negative risk:  684 689 1112 1110 424 381 93 86 151 148 63 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
288 
disease_progression 
H-positive risk:  698 685 87 1111 376 95 1110 417 148 59 149 65 
H-negative risk:  685 698 1110 1111 417 376 95 87 149 148 65 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
289 
disease_progression 
H-positive risk:  696 683 86 1112 378 98 1109 415 150 60 150 63 
H-negative risk:  683 696 1109 1112 415 378 98 86 150 150 63 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
290 
disease_progression 
H-positive risk:  685 682 87 1115 373 100 1124 411 152 60 147 64 
H-negative risk:  682 685 1124 1115 411 373 100 87 147 152 64 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
291 
disease_progression 
H-positive risk:  686 685 88 1121 376 97 1115 404 156 58 148 66 
H-negative risk:  685 686 1115 1121 404 376 97 88 148 156 66 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
292 
disease_progression 
H-positive risk:  689 685 87 1115 372 99 1123 403 155 58 150 64 
H-negative risk:  685 689 1123 1115 403 372 99 87 150 155 64 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
99 new agents 
293 
disease_progression 
H-positive risk:  683 697 92 1112 371 101 1109 410 157 59 146 63 
H-negative risk:  697 683 1109 1112 410 371 101 92 146 157 63 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
294 
disease_progression 
H-positive risk:  691 694 92 1102 373 100 1111 409 158 58 147 65 
H-negative risk:  694 691 1111 1102 409 373 100 92 147 158 65 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
295 
disease_progression 
H-positive risk:  687 693 91 1103 379 97 1109 411 161 57 145 67 
H-negative risk:  693 687 1109 1103 411 379 97 91 145 161 67 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
296 
disease_progression 
H-positive risk:  690 697 92 1096 381 97 1105 416 158 59 144 65 
H-negative risk:  697 690 1105 1096 416 381 97 92 144 158 65 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
297 
disease_progression 
H-positive risk:  683 694 94 1099 384 104 1099 419 159 59 144 62 
H-negative risk:  694 683 1099 1099 419 384 104 94 144 159 62 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
298 
disease_progression 
H-positive risk:  679 695 94 1100 387 105 1098 419 161 60 144 58 
H-negative risk:  695 679 1098 1100 419 387 105 94 144 161 58 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
299 
disease_progression 
H-positive risk:  678 691 93 1101 399 106 1098 411 161 61 142 59 
H-negative risk:  691 678 1098 1101 411 399 106 93 142 161 59 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
300 
disease_progression 
H-positive risk:  681 689 95 1105 402 103 1084 416 162 64 141 58 
H-negative risk:  689 681 1084 1105 416 402 103 95 141 162 58 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
301 
disease_progression 
H-positive risk:  678 695 94 1100 398 100 1085 418 164 65 144 59 
H-negative risk:  695 678 1085 1100 418 398 100 94 144 164 59 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
96 new agents 
302 
disease_progression 
H-positive risk:  674 695 92 1100 397 101 1100 412 159 67 146 57 
H-negative risk:  695 674 1100 1100 412 397 101 92 146 159 57 67 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
303 
disease_progression 
H-positive risk:  670 693 94 1107 394 100 1103 418 157 61 146 57 
H-negative risk:  693 670 1103 1107 418 394 100 94 146 157 57 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
304 
disease_progression 
H-positive risk:  662 693 97 1115 399 101 1101 412 154 62 148 56 
H-negative risk:  693 662 1101 1115 412 399 101 97 148 154 56 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
305 
disease_progression 
H-positive risk:  655 690 96 1115 398 101 1105 412 157 63 151 57 
H-negative risk:  690 655 1105 1115 412 398 101 96 151 157 57 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
306 
disease_progression 
H-positive risk:  659 689 95 1109 405 100 1099 414 157 65 152 56 
H-negative risk:  689 659 1099 1109 414 405 100 95 152 157 56 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
307 
disease_progression 
H-positive risk:  663 682 99 1115 406 98 1100 408 157 65 149 58 
H-negative risk:  682 663 1100 1115 408 406 98 99 149 157 58 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
308 
disease_progression 
H-positive risk:  674 685 102 1105 409 97 1095 409 156 64 148 56 
H-negative risk:  685 674 1095 1105 409 409 97 102 148 156 56 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
309 
disease_progression 
H-positive risk:  680 685 101 1099 416 94 1099 407 155 63 145 56 
H-negative risk:  685 680 1099 1099 407 416 94 101 145 155 56 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
310 
disease_progression 
H-positive risk:  676 685 100 1097 418 92 1101 405 157 66 147 56 
H-negative risk:  685 676 1101 1097 405 418 92 100 147 157 56 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
311 
disease_progression 
H-positive risk:  679 683 99 1097 417 94 1096 408 158 64 149 56 
H-negative risk:  683 679 1096 1097 408 417 94 99 149 158 56 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
312 
disease_progression 
H-positive risk:  687 679 99 1090 425 97 1090 407 157 65 151 53 
H-negative risk:  679 687 1090 1090 407 425 97 99 151 157 53 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
313 
disease_progression 
H-positive risk:  699 675 99 1084 420 99 1095 404 158 61 153 53 
H-negative risk:  675 699 1095 1084 404 420 99 99 153 158 53 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
314 
disease_progression 
H-positive risk:  698 674 100 1081 420 98 1098 405 152 64 155 55 
H-negative risk:  674 698 1098 1081 405 420 98 100 155 152 55 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
315 
disease_progression 
H-positive risk:  697 675 99 1072 425 99 1100 408 151 63 154 57 
H-negative risk:  675 697 1100 1072 408 425 99 99 154 151 57 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
316 
disease_progression 
H-positive risk:  698 675 98 1068 430 98 1105 407 150 64 148 59 
H-negative risk:  675 698 1105 1068 407 430 98 98 148 150 59 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
317 
disease_progression 
H-positive risk:  697 682 99 1064 427 96 1110 401 152 66 146 60 
H-negative risk:  682 697 1110 1064 401 427 96 99 146 152 60 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
318 
disease_progression 
H-positive risk:  695 681 99 1063 431 100 1107 406 151 65 145 57 
H-negative risk:  681 695 1107 1063 406 431 100 99 145 151 57 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
319 
disease_progression 
H-positive risk:  690 674 105 1077 425 100 1112 402 150 67 140 58 
H-negative risk:  674 690 1112 1077 402 425 100 105 140 150 58 67 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
320 
disease_progression 
H-positive risk:  688 673 107 1066 426 102 1125 401 149 69 136 58 
H-negative risk:  673 688 1125 1066 401 426 102 107 136 149 58 69 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 96 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
321 
disease_progression 
H-positive risk:  684 665 109 1069 428 102 1132 399 149 70 137 56 
H-negative risk:  665 684 1132 1069 399 428 102 109 137 149 56 70 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 101 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
322 
disease_progression 
H-positive risk:  687 653 108 1080 428 103 1122 406 150 70 139 54 
H-negative risk:  653 687 1122 1080 406 428 103 108 139 150 54 70 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 100 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
323 
disease_progression 
H-positive risk:  681 647 106 1077 434 102 1124 416 150 69 143 51 
H-negative risk:  647 681 1124 1077 416 434 102 106 143 150 51 69 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 99 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
324 
disease_progression 
H-positive risk:  670 641 106 1083 435 102 1128 416 151 69 149 50 
H-negative risk:  641 670 1128 1083 416 435 102 106 149 151 50 69 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 95 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
325 
disease_progression 
H-positive risk:  665 634 106 1074 441 101 1129 424 153 71 153 49 
H-negative risk:  634 665 1129 1074 424 441 101 106 153 153 49 71 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 96 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
326 
disease_progression 
H-positive risk:  665 638 106 1070 441 103 1130 421 153 71 152 50 
H-negative risk:  638 665 1130 1070 421 441 103 106 152 153 50 71 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 97 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
327 
disease_progression 
H-positive risk:  664 628 103 1086 433 102 1132 419 155 70 155 53 
H-negative risk:  628 664 1132 1086 419 433 102 103 155 155 53 70 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 93 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
328 
disease_progression 
H-positive risk:  675 617 106 1081 433 101 1130 417 161 71 153 55 
H-negative risk:  617 675 1130 1081 417 433 101 106 153 161 55 71 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
329 
disease_progression 
H-positive risk:  684 607 105 1081 440 103 1130 410 159 71 153 57 
H-negative risk:  607 684 1130 1081 410 440 103 105 153 159 57 71 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
330 
disease_progression 
H-positive risk:  692 609 104 1078 434 105 1128 414 162 69 150 55 
H-negative risk:  609 692 1128 1078 414 434 105 104 150 162 55 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
331 
disease_progression 
H-positive risk:  682 600 101 1087 436 108 1129 423 161 68 151 54 
H-negative risk:  600 682 1129 1087 423 436 108 101 151 161 54 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
332 
disease_progression 
H-positive risk:  682 599 99 1091 427 111 1132 425 160 69 150 55 
H-negative risk:  599 682 1132 1091 425 427 111 99 150 160 55 69 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
333 
disease_progression 
H-positive risk:  685 596 98 1083 434 111 1128 431 160 69 152 53 
H-negative risk:  596 685 1128 1083 431 434 111 98 152 160 53 69 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
334 
disease_progression 
H-positive risk:  687 595 97 1089 430 113 1127 431 160 66 152 53 
H-negative risk:  595 687 1127 1089 431 430 113 97 152 160 53 66 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
335 
disease_progression 
H-positive risk:  685 593 95 1089 428 111 1130 435 160 67 154 53 
H-negative risk:  593 685 1130 1089 435 428 111 95 154 160 53 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
336 
disease_progression 
H-positive risk:  678 596 95 1092 427 107 1133 439 163 68 150 52 
H-negative risk:  596 678 1133 1092 439 427 107 95 150 163 52 68 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
337 
disease_progression 
H-positive risk:  683 604 95 1073 431 107 1136 443 160 66 150 52 
H-negative risk:  604 683 1136 1073 443 431 107 95 150 160 52 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
338 
disease_progression 
H-positive risk:  676 604 94 1069 450 109 1135 439 160 65 148 51 
H-negative risk:  604 676 1135 1069 439 450 109 94 148 160 51 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
339 
disease_progression 
H-positive risk:  685 606 95 1065 454 109 1134 433 160 62 150 47 
H-negative risk:  606 685 1134 1065 433 454 109 95 150 160 47 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
340 
disease_progression 
H-positive risk:  675 604 94 1075 455 113 1133 437 161 59 150 44 
H-negative risk:  604 675 1133 1075 437 455 113 94 150 161 44 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
341 
disease_progression 
H-positive risk:  665 608 94 1079 457 112 1143 434 161 59 148 40 
H-negative risk:  608 665 1143 1079 434 457 112 94 148 161 40 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
342 
disease_progression 
H-positive risk:  663 610 94 1079 447 112 1151 433 162 62 146 41 
H-negative risk:  610 663 1151 1079 433 447 112 94 146 162 41 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
343 
disease_progression 
H-positive risk:  666 607 95 1084 444 114 1149 431 161 62 145 42 
H-negative risk:  607 666 1149 1084 431 444 114 95 145 161 42 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
344 
disease_progression 
H-positive risk:  661 617 94 1093 433 111 1150 426 163 62 147 43 
H-negative risk:  617 661 1150 1093 426 433 111 94 147 163 43 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
345 
disease_progression 
H-positive risk:  662 616 94 1094 427 109 1152 422 164 65 151 44 
H-negative risk:  616 662 1152 1094 422 427 109 94 151 164 44 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
346 
disease_progression 
H-positive risk:  657 620 94 1089 428 111 1164 409 163 67 152 46 
H-negative risk:  620 657 1164 1089 409 428 111 94 152 163 46 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
347 
disease_progression 
H-positive risk:  651 625 96 1082 437 113 1171 396 165 68 150 46 
H-negative risk:  625 651 1171 1082 396 437 113 96 150 165 46 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
348 
disease_progression 
H-positive risk:  659 623 96 1077 448 113 1165 396 165 67 148 43 
H-negative risk:  623 659 1165 1077 396 448 113 96 148 165 43 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
349 
disease_progression 
H-positive risk:  658 622 95 1079 447 112 1170 399 162 66 145 45 
H-negative risk:  622 658 1170 1079 399 447 112 95 145 162 45 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
350 
disease_progression 
H-positive risk:  661 625 96 1074 449 109 1166 401 163 63 146 47 
H-negative risk:  625 661 1166 1074 401 449 109 96 146 163 47 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
351 
disease_progression 
H-positive risk:  658 629 98 1070 448 106 1159 404 167 63 149 49 
H-negative risk:  629 658 1159 1070 404 448 106 98 149 167 49 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
352 
disease_progression 
H-positive risk:  666 617 100 1078 449 108 1146 408 167 63 148 50 
H-negative risk:  617 666 1146 1078 408 449 108 100 148 167 50 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
353 
disease_progression 
H-positive risk:  666 615 100 1072 460 110 1139 410 167 61 149 51 
H-negative risk:  615 666 1139 1072 410 460 110 100 149 167 51 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
354 
disease_progression 
H-positive risk:  667 608 102 1066 456 107 1148 414 171 63 149 49 
H-negative risk:  608 667 1148 1066 414 456 107 102 149 171 49 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
355 
disease_progression 
H-positive risk:  672 615 103 1067 454 105 1141 409 174 61 150 49 
H-negative risk:  615 672 1141 1067 409 454 105 103 150 174 49 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
356 
disease_progression 
H-positive risk:  670 609 104 1068 457 104 1149 408 174 59 149 49 
H-negative risk:  609 670 1149 1068 408 457 104 104 149 174 49 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
357 
disease_progression 
H-positive risk:  671 615 105 1069 456 102 1143 410 175 58 150 46 
H-negative risk:  615 671 1143 1069 410 456 102 105 150 175 46 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
358 
disease_progression 
H-positive risk:  673 625 105 1065 458 100 1138 417 171 58 145 45 
H-negative risk:  625 673 1138 1065 417 458 100 105 145 171 45 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
359 
disease_progression 
H-positive risk:  669 620 103 1075 454 104 1142 417 168 59 145 44 
H-negative risk:  620 669 1142 1075 417 454 104 103 145 168 44 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
360 
disease_progression 
H-positive risk:  667 622 103 1084 448 104 1151 406 168 59 144 44 
H-negative risk:  622 667 1151 1084 406 448 104 103 144 168 44 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
Time difference of 16.55642 mins
This is task 27
